AtonRa Partners - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
AtonRa Partners ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$264,659
-36.2%
8,370
-17.7%
0.56%
-13.6%
Q2 2023$414,896
+2.3%
10,174
-6.5%
0.64%
+8.4%
Q1 2023$405,758
-5.7%
10,887
-11.7%
0.59%
+8.0%
Q4 2022$430,263
-54.5%
12,332
-27.0%
0.55%
-41.0%
Q3 2022$945,000
+8.9%
16,884
+0.7%
0.93%
+16.4%
Q2 2022$868,000
-40.2%
16,770
-16.1%
0.80%
+1.1%
Q1 2022$1,452,000
-58.5%
19,980
-32.5%
0.79%
-35.1%
Q4 2021$3,498,000
-0.3%
29,586
+13.1%
1.22%
+3.6%
Q3 2021$3,508,000
+10.1%
26,153
+32.9%
1.17%
+0.4%
Q2 2021$3,186,000
+256.8%
19,676
+76.8%
1.17%
+193.5%
Q1 2021$893,00011,1300.40%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders